1 completed, 1 unknown. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Unknown 1 |
Follow Nucleosides: new trials by email Literature Review of Nucleosides trials Research Report on Nucleosides
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| HBsAg Decline After Pegylated-interferon-α in e Antigen Positive Chronic Hepatitis B With Nucleoside Maintenance PEG-interferon-Alfa-2A, Nucleosides - Chronic Hepatitis B | Phase 3 | Unknown | Pusan National University Hospital | 144 | 2013-05-01 | 2014-11-04 |
| Atazanavir (BMS-232632) in Combination With Ritonavir or Saquinavir, and Lopinavir/Ritonavir, Each With Tenofovir and a Nucleoside in Subjects With HIV Atazanavir + ritonavir + tenofovir + nucleoside, Atazanavir + saquinavir + tenofovir + nucleoside, Lopinavir/ritonavir + tenofovir + nucleoside - HIV Infections | Phase 3 | Completed | Bristol-Myers Squibb | 571 | 2001-11-01 | 2010-12-24 |
HIV Infections (1) · Hepatitis B, Chronic (1)
Bristol-Myers Squibb (1) · Pusan National University Hospital (1)
South Korea (1) · United States (1)
Jeong Heo, Dr (1)